Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A decline in weight and attrition of muscle in colorectal cancer patients receiving chemotherapy with bevacizumab.

A decline in weight and attrition of muscle in colorectal cancer patients receiving chemotherapy with bevacizumab. Med Oncol. 2012 Jun; 29(2):1005-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.